Rayyan Therapeutics is a biopharmaceutical company located in Hamilton, Ontario, Canada. We are implementing the latest laboratory techniques to develop our novel bioproduct drug that is used for the treatment of various cardiovascular diseases (CVD). Using a patented technology formulation, initially targeted for CVD complications in severe illnesses, we are able to dissolve and prevent the formation of blood clots. Our aim is to lower the number of deaths associated with cardiovascular diseases from #1 globally to a lower count down the list. Our impact is to create a viable treatment that gives hope to severely ill patients by allowing patients to live longer, healthier, and a happier life.
Rayyan Therapeutics is committed to improving the lives of severely ill patients by combating blood complications associated with severe illnesses.
Rayyan Therapeutics consists of medical and scientific experts with backgrounds in cardiology, pharmacology, and clinical development.